Gene · 259197
Papers4,252
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,252
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered Expression of NK Receptors in Racially/Ethnically Diverse and Risk-of-Relapse Pediatric Acute Lymphoblastic Leukemia Patients. | Biomedicines | 2025 | 40564131 | PubTator, text mining | PubMed |
| Impact of a moderate-intensity aerobic exercise intervention on systemic and uterine natural killer cells in women with unexplained recurrent pregnancy loss. | Front Immunol | 2025 | 40534886 | PubTator, text mining | PubMed |
| Changes in NK Cells and Exhausted Th Cell Phenotype in RA Patients Treated with Janus Kinase Inhibitors: Implications for Adverse Effects. | Int J Mol Sci | 2025 | 40507968 | PubTator, text mining | PubMed |
| Current PAT Landscape in the Downstream Processing of Biopharmaceuticals. | Anal Sci Adv | 2025 | 40444218 | PubTator, text mining | PubMed |
| Dap10 co-stimulation enhances the anti-HCC efficacy of NKp30 chimeric antigen receptor T cells. | Transl Oncol | 2025 | 40393250 | PubTator, text mining | PubMed |
| KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients. | Cancer Immunol Immunother | 2025 | 40372495 | PubTator, text mining | PubMed |
| Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy. | Front Immunol | 2025 | 40370457 | PubTator, text mining | PubMed |
| Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications. | Front Immunol | 2025 | 40370433 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
| The Influence of the COVID-19 Pandemic in NK Cell Subpopulations from CML Patients Enrolled in the Argentina Stop Trial. | Cells | 2025 | 40358152 | PubTator, text mining | PubMed |
| Glycosylation as an intricate post-translational modification process takes part in glycoproteins related immunity. | Cell Commun Signal | 2025 | 40325416 | PubTator, text mining | PubMed |
| Cytokine Expression and Cytolytic Effect of Natural Killer Cells are Suppressed in Septic Shock. | Scand J Immunol | 2025 | 40254928 | PubTator, text mining | PubMed |
| Functional insights into immunoglobulin superfamily proteins in invertebrate neurobiology and immunity. | Front Immunol | 2025 | 40242768 | PubTator, text mining | PubMed |
| Decreased surface receptors, function, and suboptimal osteoclasts-induced cell expansion in natural killer (NK) cells of elderly subjects. | Aging (Albany NY) | 2025 | 40146570 | PubTator, text mining | PubMed |
| SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy. | J Immunol | 2025 | 40073103 | PubTator, text mining | PubMed |
| Immunophenotypic Implications of Reverse-Circadian Glucocorticoid Treatment in Congenital Adrenal Hyperplasia. | Int J Mol Sci | 2025 | 40003944 | PubTator, text mining | PubMed |
| Natural Killer Cells in Graves' Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls. | Int J Mol Sci | 2025 | 39940745 | PubTator, text mining | PubMed |
| NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial. | Eur J Immunol | 2025 | 39931788 | PubTator, text mining | PubMed |
| BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features. | J Allergy Clin Immunol | 2025 | 39894227 | PubTator, text mining | PubMed |
| A New Antibody-Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia. | Biomolecules | 2025 | 39858511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259197/papers?page=7